Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Hold
25,000
﹤0.01% 898
2026
Q1
$278K Hold
25,000
﹤0.01% 803
2025
Q4
$410K Sell
25,000
-30,000
-55% -$467K ﹤0.01% 621
2025
Q3
$736K Buy
+55,000
New +$650K 0.01% 413

Other funds holding PATH

Marex Group's PATH Position: Q2 2026 in Review

Marex Group reduced its UiPath (PATH) stake by 12% in Q2 2026, selling an estimated $32.6K and leaving 22,498 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Marex Group first reported a position in PATH in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.2M in Q1 2024. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Marex Group held 22,498 shares of UiPath worth $245K as of Q2 2026.
  • Marex Group sold 3,058 UiPath shares in Q2 2026, an estimated $32.6K.
  • UiPath made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #938 holding.
  • Marex Group first reported a position in UiPath in Q4 2023 and has held it in 11 quarters since.
  • Marex Group's UiPath position peaked at $1.2M in Q1 2024.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.